Hepatitis B future or investigational therapies: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Joao Silva (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Hepatitis B}} | {{Hepatitis B}} | ||
{{CMG}}; {{AE}} {{JS}} | |||
==Overview== | |||
Currently, new forms of treatment, such as the combination therapy with [[interferon-α]] and [[lamivudine]] for patients who failed [[interferon-α]] monotherapy is under investigation. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Hepatitis|B]] | [[Category:Hepatitis|B]] | ||
[[Category:Viruses]] | [[Category:Viruses]] | ||
| Line 14: | Line 14: | ||
[[Category:Mature chapter]] | [[Category:Mature chapter]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Revision as of 19:07, 30 July 2014
|
Hepatitis B |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hepatitis B future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Hepatitis B future or investigational therapies |
|
Risk calculators and risk factors for Hepatitis B future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]
Overview
Currently, new forms of treatment, such as the combination therapy with interferon-α and lamivudine for patients who failed interferon-α monotherapy is under investigation.